Cullen/Frost Bankers, Inc. Novo Nordisk A S Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 115,385 shares of NVO stock, worth $10.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

115,385

Previous 115,005 0.33%

Holding current value

$10.1 Million

Previous $16.4 Million 16.31%

% of portfolio

0.19%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$119.07 - $145.42 $45,246 - $55,259	380 Added 0.33%	115,385 $13.7 Million
Q2 2024 Aug 05, 2024	BUY	$122.71 - $146.91 $61,968 - $74,189	505 Added 0.44%	115,005 $16.4 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $1,429 - $1,902	-14 Reduced 0.01%	114,500 $14.7 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $3,335 - $4,007	38 Added 0.03%	114,514 $11.8 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $5.05 Million - $11.1 Million	55,529 Added 94.2%	114,476 $10.4 Million
Q2 2023 Aug 04, 2023	BUY	$155.98 - $172.65 $2.54 Million - $2.81 Million	16,287 Added 38.18%	58,947 $9.54 Million
Q1 2023 May 05, 2023	BUY	$132.34 - $159.14 $19,718 - $23,711	149 Added 0.35%	42,660 $6.79 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $107,677 - $142,096	1,050 Added 2.53%	42,511 $5.75 Million
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $3,334 - $4,092	-35 Reduced 0.08%	41,461 $4.13 Million
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $19,409 - $22,900	-188 Reduced 0.45%	41,496 $4.62 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $18,061 - $21,832	-194 Reduced 0.46%	41,684 $4.63 Million
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $149,572 - $182,644	-1,560 Reduced 3.59%	41,878 $4.69 Million
Q3 2021 Nov 04, 2021	SELL	$84.42 - $106.62 $157,949 - $199,486	-1,871 Reduced 4.13%	43,438 $4.17 Million
Q2 2021 Aug 05, 2021	SELL	$67.66 - $84.76 $1.39 Million - $1.74 Million	-20,522 Reduced 31.17%	45,309 $3.8 Million
Q1 2021 May 05, 2021	BUY	$67.06 - $75.82 $163,693 - $185,076	2,441 Added 3.85%	65,831 $4.44 Million
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $93,662 - $108,190	1,466 Added 2.37%	63,390 $4.43 Million
Q3 2020 Nov 05, 2020	BUY	$63.69 - $70.22 $213,807 - $235,728	3,357 Added 5.73%	61,924 $4.3 Million
Q2 2020 Aug 05, 2020	BUY	$58.54 - $67.94 $2.39 Million - $2.78 Million	40,853 Added 230.63%	58,567 $3.84 Million
Q1 2020 May 01, 2020	BUY	$49.46 - $64.78 $876,134 - $1.15 Million	17,714 New	17,714 $1.07 Million
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $3,290 - $3,845	-66 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$47.54 - $53.43 $427 - $480	-9 Reduced 12.0%	66 $3,000
Q2 2019 Aug 01, 2019	BUY	$46.79 - $52.47 $280 - $314	6 Added 8.7%	75 $4,000
Q1 2019 Apr 30, 2019	BUY	$46.36 - $52.63 $3,198 - $3,631	69 New	69 $4,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Novo Nordisk A S Transaction History